USP 800 and The National Institute for Occupational Safety and Health (NIOSH) recommends that employers develop a medical surveillance program to monitor the safety of the employees working with hazardous drugs, including wipe sampling every 6 months.
This recommendation includes using baseline data and ongoing monitoring of environmental hazards as a way to assess the potential risk of employee exposure to hazardous drugs. Read More >
ChemoGLO is passionate about the impacts of hazardous drugs on patients and healthcare workers. Evaluating environmental exposure to chemotherapy in the workplace is the first step in providing a healthier, safer work environment.
ChemoGLO focuses on hazardous drug detection and removal in clinical, laboratory, and institutional settings by offering two USP 800 compliant products.
This post is related to:
Stay informed on pharmacy supply chain news, market trends, and product releases by subscribing to RXinsider’s emails, newsletters, and publications. If building awareness with pharmacy management is part of your marketing strategy, consider advertising with RXinsider.
